Infectious agents are not necessary for murine atherogenesis

Journal of Experimental Medicine

Volumn 191, Issue 8, 2000, Pages 1437-1441

  Wright, Samuel D ^a   Burton, Charlotte ^a   Hernandez, Melba ^a   Hassing, Heide ^a   Montenegro, Judy ^a   Mundt, Steve ^a   Patel, Sushma ^a   Card, Deborah J ^a   Hermanowski Vosatka, Anne ^a   Bergstrom, James D ^a   Sparrow, Carl P ^a   Detmers, Patricia A ^a   Chao, Yu Sheng ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Apolipoprotein E knockout; Atherosclerosis; Cholesterol; Germ free animal; Toll

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; INFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; GERM-FREE LIFE; HUMANS; INFECTION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC;

EID: 0034678402     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.8.1437     Document Type: Article

References (37)

1. Fabricant, C.G., J. Fabricant, M.M. Litrenta, and C.R. Minick. 1978. Virus-induced atherosclerosis. J. Exp. Med. 148: 335-340.
2. Fabricant, C.G., J. Fabricant, C.R. Minick, and M.M. Litrenta. 1983. Herpesvirus-induced atherosclerosis in chickens. Fed. Proc. 42:2476-2479.
3. Epstein, S.E., E. Speir, Y.F. Zhou, E. Guetta, M. Leon, and T. Finkel. 1996. The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet. 348(Suppl.): 13-17.
4. Patel, P., M.A. Mendell, D. Carrington, D.P. Strachan, E. Leatham, N. Molineaux, J. Levy, C. Blakeston, C.A. Seymour, and A.J. Camm. 1997. Heart disease and cardiovascular risk factors. BMJ. 311:711.
5. Danesh, J., R. Collins, and R. Peto. 1997. Chronic infections and coronary heart disease: is there a link? Lancet. 350:430-436.
6. Kuo, C.C., J.T. Grayston, L.A. Campbell, A. Goo, R.W. Wissler, and E.P. Benditt. 1995. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc. Natl. Acad. Sci. USA. 92:6911-6914.
7. Davidson, M., C.C. Kuo, J.P. Middaugh, L.A. Campbell, S.P. Wang, W.P. Newman III, J.C. Finley, and J.T. Grayston. 1998. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 98:628-633.
8. Campbell, L.A., E.R. O'Brien, A.L. Capuccio, C.C. Kuo, S.P. Wang, D. Stewart. D.L. Patton, P.I. Cummings, and J.T. Grayston. 1995. Detection of Chlamydia pneuomoniae TWAR in human coronary atherectomy tissues. J. Infect. Dis. 172:585-588.
9. Coles, K.A., A.J. Plant, T.V. Riley, D.W. Smith, B.M. McQuillan, and P.L. Thompson. 1999. Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis. Am. J. Cardiol 84:825-828.
10. Daus, H., C. Ozbek, D. Saage, B. Scheller, H. Schiefffer, M. Pfreundschuh, and A. Grause. 1998. Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation. Cardiology. 90:83-88.
11. Moazed, T.C., C.C. Kuo, J.T. Grayston, and L.A. Campbell. 1998. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J. Infect. Dis. 177: 1322-1325.
12. Ross, R. 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:115-126.
13. Smith, J.D., E. Trogan, M. Ginsberg, C. Grigaux, J. Tian, and M. Miyata. 1995. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA. 92:8264-8268.
14. Grayston, J.T. 1999. Does Chlamydia pneumoniae cause atherosclerosis? Arch. Surg. 134:930-934.
15. Campbell, L.A., C.C. Kuo, and J.T. Grayston. 1998. Chlamydia pneumoniae and cardiovascular disease. Emerg. Infect. Dis. 4:571-579.
16. Noll, G. 1998. Pathogenesis of atherosclerosis: a possible relation to infection. Atherosclerosis. 140 (Suppl.):3-9.
17. Gupta, S., and A.J. Camm. 1998. Is there an infective aetiology to atherosclerosis? Drugs Aging. 13:1-7.
18. Mehta, J.L., T.G. Saldeen, and K. Rand. 1998. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J. Am. Coll. Cardiol. 31:1217-1225.
19. Taylor, D.N., and M.J. Blaser. 1991. The epidemiology of Helicobacter pylori infection. Epidemiol. Rev. 13:42-59.
20. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. 1994. NIH Consensus Conference. Helicobacter pylori in Peptic Ulcer Disease. JAMA. 272:65-69.
21. Plump, A.S., J.D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow. 1992. Sever hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
22. Piedrahita, J.A., S.H. Zhang, J.R. Hagaman, P.M. Oliver, and N. Maeda. 1992. Generation of mice earning a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad Sci. USA. 89:4471-4475.
23. Nakashima, Y., A.S. Plump, E.W. Raines, J.E. Breslow, and R. Ross. 1994. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:133-140.
24. Folch, J., M. Lees, and G.A. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 226:497-509.
25. Gamble, W., M. Vaughn, H.S. Kruth, and J. Avigan. 1978. Procedure for determination of tree and total cholesterol in micro-or nanogram amounts suitable for studies with cultured cells. J. Lipid Res. 19:1068-1970.
26. Heider, J.G., and R.L. Boyett. 1978. The picomole determination of tree and total cholesterol in cells in culture. J. Lipid Res. 19:514-518.
27. Vogel, S. 1992. Insights into the genetic and molecular basis of LPS responsiveness and macrophage differentiation. In Tumor Necrosis Factors: the Molecules and Their Emerging Role in Medicine. B. Beutler, editor. Raven Press, Ltd., New York. 485-513.
28. Wright, S.D. 1999. Innate recognition of microbial lipids. In Inflammation: Basic Principles and Clinical Correlates. 3rd ed. J.I. Gallin and R. Snyderman, editors. Lippincott Williams and Wilkins, Philadelphia. 525-535.
29. Poltorak, A., X. He, I. Smirnova, M.Y. Lin, C.V. Huffel, X. Du, D. Birdwell, R. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57HL/10ScCr mice: mutations in Tlr4 gene. Science: 282:2085-2088.
30. Wright, S.D. 1999. Toll, a new piece in the puzzle of innate immunity. J. Exp. Med. 189:605-609.
31. 1984. The germ-free animal in biomedical research. In Laboratory Animal Handbooks 9. M.E. Coates and B.E. Gustafsson, editors. Laboratory Animals, Ltd., London. 100-108.
32. Anderson, J.L., M.B. Muhlestein, J. Carlquist, A. Allen, S. Trehan, C. Nielson, S. Hall, J. Brady, M. Egger, B. Horne, and T. Lim. 1999. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. Circulation 99:1540-1547.
33. Hu, H., G.N. Pierce, and G. Zhong. 1999. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Invest. 103:747-753.
34. Moazed, T.C., A. Campbell, M.E. Rosenfeld, J.T. Grayston, and C.-C. Kuo. 1999. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J. Infect. Dis. 180:238-241.
35. Danesh, J., R. Collins, P. Applehy, and R. Peto. 1998. Association of fibrogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 279:1477-1482.
36. Pickup, J.C., M.B. Matock, G.D. Chusney, and D. Burt. 1997. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 40:1286-1292.
37. Ingenbleek, Y., and L. Bernstein. 1999. The stressful condition as a nutritionally dependent adaptive dichotomy. Nutrition. 15:305-320.